Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.

[1]  T. Svensson.  On the role of central noradrenaline in the regulation of motor activity and body temperature in the mouse , 2005, Naunyn-Schmiedebergs Archiv für Pharmakologie.

[2]  M. Nakamura,et al.  Reversal of the reserpine-induced ptosis by l-threo-3,4-dihydroxy-phenylserine (l-threo-DOPS), a (−)-norepinephrine precursor, and its potentiation by imipramine or nialamide , 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  Z. Kleinrok,et al.  An analysis of dopa-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase , 2004, Psychopharmacologia.

[4]  R. Takahashi,et al.  The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain , 1985, Psychiatry Research.

[5]  J. Warsh,et al.  Rat Brain and Plasma Norepinephrine Glycol Metabolites Determined by Gas Chromatography‐Mass Fragmentography , 1981, Journal of neurochemistry.

[6]  M. Rahman,et al.  IV. Determination of aromatic L-amino acid decarboxylase in serum of various animals by high-performance liquid chromatography with electrochemical detection☆ , 1981 .

[7]  D. Edwards,et al.  Effects of amino acid precursors on catecholamine synthesis in the brain. , 1981, Progress in neuro-psychopharmacology.

[8]  T. Kato,et al.  A new and highly sensitive voltammetric assay for aromatic L-amino acid decarboxylase activity by high-performance liquid chromatography. , 1979, Analytical biochemistry.

[9]  C. Inagaki,et al.  Enzymatic decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat heart. , 1978, Japanese journal of pharmacology.

[10]  C. Inagaki,et al.  Inhibitory effect of (+)threo-3,4-dihydroxy-phenylserine (DOPS) on decarboxylation of (-)threo-dops. , 1976, Japanese journal of pharmacology.

[11]  R. Tissot,et al.  The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine. , 1975, The Journal of pharmacology and experimental therapeutics.

[12]  L. Molander,et al.  Investigation of the mechanism by which L-DOPA induces gnawing in mice. , 2009, Acta pharmacologica et toxicologica.

[13]  A. Cornish-Bowden,et al.  Statistical considerations in the estimation of enzyme kinetic parameters by the direct linear plot andother methods. , 1974, The Biochemical journal.

[14]  O. Benkert,et al.  Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine. , 1973, Neuropharmacology.

[15]  S. Gershon,et al.  L-Dopa and imipramine: biochemical and behavioral interaction. , 1972, European journal of pharmacology.

[16]  R. Tissot,et al.  Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase. , 1971, Biochemical pharmacology.

[17]  W. Burkard,et al.  Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral Decarboxylase , 1967, Nature.

[18]  H. Lidvall,et al.  The urinary output of catecholamines in narcolepsy under resting conditions and following administration of dopamine, DOPA, and DOPS. , 1966, Scandinavian journal of clinical and laboratory investigation.

[19]  W. Burkard,et al.  INHIBITION OF DECARBOXYLASE OF AROMATIC AMINO ACIDS BY 2,3,4-TRIHYDROXYBENZYLHYDRAZINE AND ITS SERYL DERIVATIVE. , 1964, Archives of biochemistry and biophysics.

[20]  W. Lovenberg,et al.  Aromatic L-amino acid decarboxylase. , 1962, The Journal of biological chemistry.